title: Medical versus pharmaceutical continuing education: are both appropriate for the pharmacist?
abstract: Continuing education (CE) courses in pharmacy and medicine often overlap with regard to their informational content. At the present time, however, it is feasible that two pharmacists could attend the same national meeting that has continuing medical education (CME) approval status and only one of them would receive CE credit from his state board of pharmacy. Therefore, a survey of 51 state board of pharmacy policies regarding acceptance of CME was conducted. Forty-five of the 51 boards of pharmacy require CE for relicensure. Twenty percent of state boards requiring CE accept CME credit without review, 24 percent do not accept CME credit, and the remaining 56 percent review submitted requests for CME credit. A general lack of uniformity exists among state boards regarding policies pertaining to CE credit. If CME credit was universally accepted, pharmacists would benefit from the increased availability of CE, the building of collegial relationships with other healthcare professionals, and the cost savings of combining courses that mutually benefit both pharmacists and physicians.
authors.affiliation: Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock 72205.
authors.forename: S F
authors.initials: SF
authors.lastname: Gardner
authors.forename: E J
authors.initials: EJ
authors.lastname: Stanek
authors.forename: M A
authors.initials: MA
authors.lastname: Munger
mesh_terms: D000068:Accreditation / Q000592:standards*; D003625:Data Collection; D004502:Education, Medical, Continuing / Q000592:standards*; D004513:Education, Pharmacy, Continuing / Q000592:standards*; D006801:Humans; D010595:Pharmacists; D011640:Public Policy; D013044:Specialty Boards; D014481:United States